New drugs to mitigate inflammation in the TME without causing immunosuppression are highly significant in chemo- and immunotherapies.
← all excerpts
Teaching the basics of repurposing mitochondria-targeted drugs: From Parkinson's disease to cancer and back to Parkinson's disease.
1
—
—